Jenny Chaplin
Corporate Officer/Principal bei BELLICUM PHARMACEUTICALS, INC.
Profil
Jenny Chaplin is currently the Vice President-Strategic Operations at Bellicum Pharmaceuticals, Inc. She previously worked at Pfizer Inc. She obtained an undergraduate degree from the University of the Witwatersrand.
Aktive Positionen von Jenny Chaplin
| Unternehmen | Position | Beginn |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2018 |
Ausbildung von Jenny Chaplin
| University of the Witwatersrand | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
